Karen Thomas

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

Peter A. LeWitt, Ali R. Rezai, Maureen A. Leehey et al. · The Lancet Neurology · 2011 · 661 citations

Advanced Parkinson, Aav2-gad Gene Therapy, Neurological Progress +5

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

Long Covid, Antimicrobial Stewardship, Antibiotics +7

Predicting and evaluating response to omalizumab in patients with severe allergic asthma

Jean Bousquet, Klaus F. Rabe, Marc Humbert et al. · Respiratory Medicine · 2007 · 302 citations · Full text

Asthma, Translational Medicine, Allergy +5

Reliability and Validity of the Tinetti Mobility Test for Individuals With Parkinson Disease

Deb Kegelmeyer, Anne Kloos, Karen Thomas et al. · Physical Therapy · 2007 · 225 citations · Full text

Evaluation of two treatment regimens of pralidoxime (1 gm single bolus dose vs 12 gm infusion) in the management of organophosphorus poisoning.

Samantha Johnson, J V Peter, Karen Thomas et al. · PubMed · 1996 · 79 citations

Pharmacotherapy, Adverse Drug Reaction, Placebo Infusion +16